3D-Organotypic Cultures and Future Perspectives of Such Techniques in Predictive Toxicology
Fozia Noor, Saarland University, speaking at Stem Cells & Bioprocessing Europe 2012.
Stem Cell Therapy for Joint Restoration: A Research Perspective
Professor Cosimo De Bari, University of Aberdeen, speaking at Stem Cells & Bioprocessing 2012.
Development of a 3D Culture System for an in vitro Model of Human Trabecular Meshwork
Susan Sharfstein, University of Albany, speaking at Stem Cells & Bioprocessing Europe 2012.
The Famous vs. The Inconvenient – or Why Use 3D-Culture Systems
Eric Gottwald, Karlsruhe Institute of Technology, speaking at Stem Cells & Bioprocessing Europe 2012.
Technology Spotlight: Manufacturing Cell Therapy Products – Current and Future Challenges
Christian Bos, Lonza AG, speaking at Stem Cells & Bioprocessing 2012.
Epigenetic Characterization of the FMR1 Gene and Aberrant Neurodevelopment in Human Induced Pluripotent Stem Cell Models of Fragile X Syndrome
Dr Steven Sheridan, Harvard Medical School, speaking at Stem Cells 2012
Blurring Boundaries between Research and Care in Biobanking: Exploring Tensions in Governance
Conor Douglas, Vrije University of Amsterdam Medical Centre, speaking at European Lab Automation 2012
An Overview of the Regulatory Landscape Relevant to Tissue and Cell Based Therapies within the EU, considering both Adult and Embryonic Stem Cells
Julian Hitchcock, Lawford Davies Denoon, speaking at Stem Cells & Bioprocessing Europe 2012.
Tissue Based Diagnostics for Predicting Drug Response: Challenges and Opportunities
Hartmut Juhl, Indivumed GmbH and Inostics GmbH, speaking at European Lab Automation 2012